Inventor · disambiguated record
Michael J. Bishop
Also filed as: BISHOP MICHAEL · BISHOP MICHAEL J · BISHOP MICHAEL JOSEPH
19 granted patents·14 pending applications·348 citations·filing 1994–2024
94Inventor score
Files withDELTA PHARMACEUTICALS INC6GLAXOSMITHKLINE IP DEV LTD4KLOTHO THERAPEUTICS INC4BRIDGENE BIOSCIENCES INC3CHANG KWEN-JEN2
Top patents by PatentIndex Score
33 records- 0195US5574159AOpioid compounds and methods for making thereforDELTA PHARMACEUTICALS INC·Filed 1995·Granted Nov 12, 1996·113 cites·8 claims
- 0293US5681830AOpioid compoundsDELTA PHARMACEUTICALS INC·Filed 1994·Granted Oct 28, 1997·65 cites·24 claims
- 0392US11697665B2C-mannoside compounds useful for the treatment of urinary tract infectionsGLAXOSMITHKLINE IP DEV LTD·Filed 2021·Granted Jul 11, 2023·3 cites·20 claims
- 0483US11111262B2C-mannoside compounds useful for the treatment of urinary tract infectionsGLAXOSMITHKLINE IP DEV LTD·Filed 2020·Granted Sep 7, 2021·1 cites·4 claims
- 0580US5985880ACompositions and methods for reducing respiratory depression and attendant side effects of mu opioid compoundsDELTA PHARMACEUTICALS INC·Filed 1997·Granted Nov 16, 1999·39 cites·24 claims
- 0679US6919350B2Compositions and methods for reducing respiratory depression and attendant side effects of mu opioid compoundsARDENT PHARMACEUTICALS INC·Filed 2001·Granted Jul 19, 2005·9 cites·29 claims
- 0777US5807858ACompositions and methods for reducing respiratory depressionDELTA PHARMACEUTICALS INC·Filed 1996·Granted Sep 15, 1998·54 cites·46 claims
- 0877US2025179059A1Anticancer compoundsUNIV CALIFORNIA·Filed 2024·Application pending·0 cites
- 0974US6300332B1Methods for reducing respiratory depression and attendant side effects of mu opioid compoundsDELTA PHARMACEUTICALS INC·Filed 1999·Granted Oct 9, 2001·23 cites·25 claims
- 1073US5552404AOpioid compounds and methods for using sameDELTA PHARMACEUTICALS INC·Filed 1995·Granted Sep 3, 1996·36 cites·20 claims
- 1171US12162870B2Anticancer compoundsUNIV CALIFORNIA·Filed 2022·Granted Dec 10, 2024·0 cites·34 claims
- 1270US8633175B2Compounds as antagonists or inverse agonists at opioid receptorsCOWAN DAVID JOHN·Filed 2007·Granted Jan 21, 2014·2 cites·9 claims
- 1363US2025388568A1Nlrp3 inhibitorsKODIAK SCIENCES INC·Filed 2023·Application pending·0 cites
- 1462US12351597B2Substituted biphenyl or phenylheteroaryl-mannosides as antagonists of FimHGLAXOSMITHKLINE IP DEV LTD·Filed 2020·Granted Jul 8, 2025·0 cites·7 claims
- 1562US2008193383A1Compositions and methods for reducing respiratory depression and attendant side effects of mu opioid compoundsCHANG KWEN-JEN·Filed 2008·Application pending·0 cites
- 1661US2023151017A1Therapeutic agents targeting gpr35PROMETHEUS BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 1760US6884801B1Imidazoline derivatives as alpha-1A adrenoceptor ligandsSMITHKLINE BEECHAM CORP·Filed 2000·Granted Apr 26, 2005·2 cites·21 claims
- 1859US8822518B2Compounds as antagonists or inverse agonists of opioid receptors for treatment of addictionGLAXOSMITHKLINE LLC·Filed 2013·Granted Sep 2, 2014·0 cites·10 claims
- 1959US7625909B2Substituted quinazolinone compoundsNOVARTIS VACCINES & DIAGNOSTIC·Filed 2004·Granted Dec 1, 2009·1 cites·21 claims
- 2059US2025170107A1Imidazopyridine inhibitors of tyrosine kinaseBRIDGENE BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 2156US2024189278A1Novel compounds and methods for increasing klotho gene expressionKLOTHO THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2256US2005255151A1Compositions and methods for reducing respiratory depression and attendant side effects of mu opioid compoundsCHANG KWEN-JEN·Filed 2005·Application pending·0 cites
- 2355US2014323487A1Novel Compounds As Antagonists Or Inverse Agonists At Opioid ReceptorsGLAXOSMITHKLINE LLC·Filed 2014·Application pending·0 cites
- 2454US2024216514A1Novel antitumor compounds and related methods of manufacture and useKLOTHO THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2551US12297223B2CompoundsGLAXOSMITHKLINE IP DEV LTD·Filed 2020·Granted May 13, 2025·0 cites·20 claims
- 2650US2010105654A1Substituted quinazolinone compoundsBOYCE RUSTUM S·Filed 2009·Application pending·0 cites
- 2748US12409177B2FGFR inhibitors for the treatment of cancerBRIDGENE BIOSCIENCES INC·Filed 2020·Granted Sep 9, 2025·0 cites·12 claims
- 2847US2023279006A1Novel compounds and methods for increasing klotho gene expressionKLOTHO THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2946US2022288069A1Inhibitors of tyrosine kinaseBRIDGENE BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 3043US2023278953A1Water soluble prodrugs of ptba for use in hdac inhibition and enhancing renal recovery following acute kidney injuryKLOTHO THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3141US9062037B2Tazarotene derivativesSTIEFEL LABORATORIES·Filed 2014·Granted Jun 23, 2015·0 cites·22 claims
- 3238US10294214B2Positive allosteric modulators of human melanocortin-4 receptorUNIV VANDERBILT·Filed 2017·Granted May 21, 2019·0 cites·3 claims
- 3325US2012115909A1Tazarotene derivativesGE XUE·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael J. Bishop files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →